<?xml version='1.0' encoding='utf-8'?>
<document id="30243558"><sentence text="[The serotonin syndrome: An updated literature review]."><entity charOffset="5-14" id="DDI-PubMed.30243558.s1.e0" text="serotonin" /></sentence><sentence text="The serotonin syndrome is a potentially deadly complication resulting from drug adverse effect, drug-drug interaction or overdose involving one or more serotonergic molecules, e"><entity charOffset="4-13" id="DDI-PubMed.30243558.s2.e0" text="serotonin" /></sentence><sentence text="g" /><sentence text=", antidepressants, psychostimulants and sometimes an &quot;ignored&quot; serotonergic compound" /><sentence text=" The serotonin syndrome typically consists of a clinical triad including cognitive/behavioral, neurovegetative and neuromuscular features"><entity charOffset="5-14" id="DDI-PubMed.30243558.s5.e0" text="serotonin" /></sentence><sentence text=" However, this syndrome is characterized by major clinical heterogeneity, making the diagnosis difficult in practice" /><sentence text=" Moreover, many practitioners are quite unaware of this syndrome" /><sentence text=" Available scores and classifications can help physicians in their diagnosis approach" /><sentence text=" Knowing the responsible molecules, their potential interactions and mechanisms of action can help preventing this complication allowing therapeutic education among patients" /><sentence text=" This updated article reviews the clinical presentation, prevention, management, and pathophysiology of the serotonin syndrome, and addresses the most recent advances in pharmacogenetics regarding this syndrome"><entity charOffset="108-117" id="DDI-PubMed.30243558.s10.e0" text="serotonin" /></sentence><sentence text="" /></document>